Literature DB >> 19622091

Inflammatory biomarkers in airways of patients with severe asthma compared with non-severe asthma.

P Macedo1, M Hew, A Torrego, S Jouneau, T Oates, A Durham, K F Chung.   

Abstract

BACKGROUND: About 5-10% of patients with asthma suffer from poorly-controlled disease despite corticosteroid (CS) therapy.
OBJECTIVE: We determined whether there were any differences in inflammatory biomarkers between severe and non-severe asthma patients.
METHODS: Nineteen severe and 20 non-severe asthma patients were recruited and underwent collection of induced sputum, bronchoalveolar lavage (BAL) fluid and bronchial biopsies.
RESULTS: Biopsy results showed no differences in eosinophils (major basic protein positive), neutrophils, macrophages, T cells and mast cells in the bronchial submucosa. However, subbasement membrane (SBM) thickness and smooth muscle area were increased in the biopsies. No significant differences were observed in the induced sputum inflammatory cells. In BAL fluid, there was a significant increase in neutrophils but a significant decrease in macrophages. Eosinophil counts were non-significantly increased threefold in both sputum and BAL in severe asthma. Levels of IL-8 and IL-13 in sputum supernatants were similar in both groups of asthma patients. There was a significant inverse correlation between post-bronchodilator forced expiratory volume in 1 s and provocative concentration of methacholine causing a 20% fall in FEV(1) with SBM thickness.
CONCLUSION: Differences in inflammatory cells were observed mainly in terms of increased neutrophils and reduction in macrophage numbers in BAL fluid with a trend towards increased eosinophils in severe asthma compared with non-severe asthma. However, the most notable features are the increase in features of airway wall remodelling of SBM thickness and smooth muscle area.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19622091     DOI: 10.1111/j.1365-2222.2009.03319.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  18 in total

Review 1.  Drug development for severe asthma: what are the metrics?

Authors:  Cynthia B Robinson; Joanne Leonard; Reynold A Panettieri
Journal:  Pharmacol Ther       Date:  2012-05-22       Impact factor: 12.310

Review 2.  Developments in the field of allergy in 2009 through the eyes of Clinical and Experimental Allergy.

Authors:  H W Chu; C M Lloyd; W Karmaus; P Maestrelli; P Mason; G Salcedo; J Thaikoottathil; A J Wardlaw
Journal:  Clin Exp Allergy       Date:  2010-11       Impact factor: 5.018

Review 3.  Overcoming reduced glucocorticoid sensitivity in airway disease: molecular mechanisms and therapeutic approaches.

Authors:  John A Marwick; Ian M Adcock; Kian Fan Chung
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

4.  Evaluation of dicarbonyls generated in a simulated indoor air environment using an in vitro exposure system.

Authors:  Stacey E Anderson; Laurel G Jackson; Jennifer Franko; J R Wells
Journal:  Toxicol Sci       Date:  2010-03-03       Impact factor: 4.849

5.  Transforming growth factor-β and nuclear factor E2–related factor 2 regulate antioxidant responses in airway smooth muscle cells: role in asthma.

Authors:  Charalambos Michaeloudes; Po-Jui Chang; Mario Petrou; Kian Fan Chung
Journal:  Am J Respir Crit Care Med       Date:  2011-10-15       Impact factor: 21.405

6.  Asthma, asthma control and risk of acute myocardial infarction: HUNT study.

Authors:  Aivaras Cepelis; Ben M Brumpton; Lars E Laugsand; Håvard Dalen; Arnulf Langhammer; Imre Janszky; Linn B Strand
Journal:  Eur J Epidemiol       Date:  2019-09-11       Impact factor: 8.082

7.  Longitudinal changes in airway remodeling and air trapping in severe asthma.

Authors:  Chad A Witt; Ajay Sheshadri; Luke Carlstrom; Jaime Tarsi; James Kozlowski; Brad Wilson; David S Gierada; Eric Hoffman; Sean B Fain; Janice Cook-Granroth; Geneline Sajol; Oscar Sierra; Tusar Giri; Michael O'Neill; Jie Zheng; Kenneth B Schechtman; Leonard B Bacharier; Nizar Jarjour; William Busse; Mario Castro
Journal:  Acad Radiol       Date:  2014-08       Impact factor: 3.173

8.  Regulation of Wnt4 in chronic obstructive pulmonary disease.

Authors:  Andrew L Durham; Alistair McLaren; Brian P Hayes; Gaetano Caramori; Chris L Clayton; Peter J Barnes; K Fan Chung; Ian M Adcock
Journal:  FASEB J       Date:  2013-03-05       Impact factor: 5.191

9.  Corticosteroid insensitivity of chemokine expression in airway smooth muscle of patients with severe asthma.

Authors:  Po-Jui Chang; Pankaj K Bhavsar; Charalambos Michaeloudes; Nadia Khorasani; Kian Fan Chung
Journal:  J Allergy Clin Immunol       Date:  2012-09-01       Impact factor: 10.793

10.  Airway smooth muscle hyperproliferation is regulated by microRNA-221 in severe asthma.

Authors:  Mark M Perry; Josie E Baker; David S Gibeon; Ian M Adcock; Kian Fan Chung
Journal:  Am J Respir Cell Mol Biol       Date:  2014-01       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.